Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Study of LY2875358 in Japanese Participants With Advanced Cancer [Phase 1]
Phase 1 clinical trial of LY2875358 in Japanese participants with advanced cancer has completed, including non-small cell lung cancer and ly…
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment [Phase 1]
Phase 1 trial evaluating total marrow and total lymph node irradiation with fludarabine and melphalan followed by donor stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Standardized Nursing Intervention Protocol for HCT Patients [NA]
This document reports the completion of a clinical trial evaluating a standardized nursing intervention protocol for hematopoietic cell tran…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant [NA]
Clinical trial update describing a completed study evaluating blood changes in patients at high risk of cytomegalovirus infection after dono…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain [Phase 1]
Phase 1 trial evaluating oral bicarbonate as an adjuvant for pain reduction in patients with tumor-related pain was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-05-29Clinical Trial Update: Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
A clinical trial evaluating perceived burden in late-stage cancer patients and their caregivers has been withdrawn.
-
CLINICAL_TRIALS research · 2015-05-27Clinical Trial Update: Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) [Phase 2]
Phase 2 study evaluating myeloablative cord blood transplantation for leukemia and lymphoma has been terminated.
-
CLINICAL_TRIALS research · 2015-05-19Clinical Trial Update: FDG PET-CT for Lymphoma Radiotherapy Planning Version 1.3 [NA]
This document updates a clinical trial evaluating FDG PET-CT for radiotherapy planning in lymphoma (version 1.3). The trial status is report…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of UCN-01 with prednisone in adults with lymphoma or solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma [Phase 1]
This clinical trial update reports completed Phase 1 results evaluating a monoclonal antibody therapy in patients with recurrent or refracto…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma [Phase 1]
Update on a Phase 1 clinical trial of the LMB-2 immunotoxin in young patients with relapsed or refractory leukemia or lymphoma; the study ha…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Depsipeptide in Treating Patients With Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating depsipeptide (romidepsin) in lymphoma patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia [Phase 1]
Phase 1 study evaluating UCN-01 in combination with fludarabine for recurrent or refractory leukemia or lymphoma; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Flavopiridol in Treating Patients With Refractory Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of flavopiridol in patients with refractory cancers, including lymphoma, prostate canc…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
The entry details the completion of a Phase 1 trial evaluating Bryostatin 1 in combination with Interleukin-2 in patients with refractory so…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Immunotoxin in Treating Patients With Leukemia or Lymphoma [Phase 1]
This is a Phase 1 clinical trial update describing an immunotoxin used to treat leukemia or lymphoma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma [Phase 1]
A Phase 1 study sponsored by the National Cancer Institute evaluating arsenic trioxide in pediatric patients with refractory leukemia or lym…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer [Phase 1]
A Phase 1 study evaluating perifosine in patients with refractory solid tumors and hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Unrelated Donor Transplant for Malignant and Non-Malignant Disorders [Phase 2]
Phase 2 trial of unrelated donor transplantation for malignant and non-malignant hematologic disorders; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Study of Bortezomib in Combination With Cyclophosphamide and Rituximab [Phase 2]
Phase 2 study of bortezomib in combination with cyclophosphamide and rituximab in mantle cell lymphoma and other lymphomas has completed wit…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies [Phase 1]
Open-label Phase 1 dose-escalation study of 4SC-205, an Eg5 kinesin-spindle inhibitor, in patients with advanced solid tumors and malignant …
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas [Phase 1]
Phase 1 clinical trial update of Aneustat (OMN54) in patients with advanced cancer and lymphomas has completed. The document lists the study…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction [Phase 1]
Phase 1 study of ixabepilone in patients with advanced solid tumors or lymphoma (including liver dysfunction) has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
SWOG's S0334 trial, which analyzes chromosomal abnormalities in patients with newly diagnosed multiple myeloma and other blood diseases, has…
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia [Phase 2]
A Phase 2 SWOG trial evaluating observation or combination chemotherapy with bortezomib, thalidomide, and rituximab followed by two autologo…